• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More or Call (407) 374-6986

Friday 12/14/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

treatment

  • 12:06 PM

    ANAHEIM, CA, June 06, 2018 (GLOBE NEWSWIRE) — BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced the Company recently sold 5.5 million shares of common stock in a private placement at a price of $0.20 per share for proceeds of $1.1 million. The $0.20 price paid by both new and existing investors represents a premium to the current market price. Investors also received 100% warrant coverage

    Read more
  • 1:40 PM

    – Dr. Larrieux brings significant experience managing analytical development quality control of immunotherapies to treat cancer and small molecule therapies at pharmaceutical and biotechnology organizations NEW YORK, ATNM, (GLOBE NEWSWIRE) — Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that Jeannine Larrieux, Ph.D. has been appointed Director of Analytical Development. Dr. Larrieux will be responsible for analytical assay development, conducting biologics license application (BLA)

    Read more
  • 3:50 PM

    MELBOURNE, Australia, Jan. 13, 2016, PPCH, /PRNewswire/ — Propanc Health Group Corporation (OTCQB: PPCH) (“Propanc” or “the Company”), an emerging healthcare company focusing on development of new and proprietary treatments for cancer patients suffering from pancreatic, ovarian and colorectal cancers, today announced the Company received a further $525,000 tranche from an institutional investor in order to progress their lead product, PRP, towards human trials. To date, the Company has received approximately $2.4 Million from the Institutional Investor since the Securities

    Read more
  • 3:53 PM

    http://www.publicwire.comZalemark’s Hispanic Shopping Network, Compralux(TM) Will Begin Testing on DirectTV Primetime Position @ 10:00AM Beginning Saturday March 29th, 2014 LOS ANGELES, April 1, Apr 01, 2014 (GLOBE NEWSWIRE via COMTEX) — Zalemark Holding Company, Inc. (OTC:ZMRK) announces it will commence airing its Compralux(TM) show on DirectTV beginning March 29, 2014. The first show will be the amazing skin brand, Onsen(TM), followed by additional shows featuring our famous jewelry brands. Zalemark’s COO, Ray Ruiz states, “We are excited to have this

    Read more
Public Wire Banner